Revisiones en Cancer
SJR0.102
ES
ESJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.102 | Q4 | 0.0% | |
| 2024 | — | — | 0.100 | Q4 | 0.0% | |
| 2023 | — | — | 0.100 | Q4 | 6.2% | |
| 2022 | — | — | 0.101 | Q4 | 11.2% | |
| 2021 | — | — | 0.100 | Q4 | 12.0% | |
| 2020 | — | — | 0.100 | Q4 | 0.0% | |
| 2019 | — | — | 0.100 | Q4 | 1.3% | |
| 2018 | — | — | 0.100 | Q4 | 0.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
0213-8573
country
EScoverage
1992-2019, 2021-2025